Literature DB >> 20490505

Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow.

Sachiyo Kogita1, Yasuharu Imai, Masahiro Okada, Tonsok Kim, Hiromitsu Onishi, Manabu Takamura, Kazuto Fukuda, Takumi Igura, Yoshiyuki Sawai, Osakuni Morimoto, Masatoshi Hori, Hiroaki Nagano, Kenichi Wakasa, Norio Hayashi, Takamichi Murakami.   

Abstract

OBJECTIVE: To retrospectively investigate enhancement patterns of hepatocellular carcinoma (HCC) and dysplastic nodule (DN) in the hepatobiliary phase of gadolinium-ethoxybenzyl-diethylenetriamine (Gd-EOB-DTPA)-enhanced MRI in relation to histological grading and portal blood flow.
METHODS: Sixty-nine consecutive patients with 83 histologically proven HCCs and DNs were studied. To assess Gd-EOB-DTPA uptake, we calculated the EOB enhancement ratio, which is the ratio of the relative intensity of tumorous lesion to surrounding nontumorous area on hepatobiliary phase images (post-contrast EOB ratio) to that on unenhanced images (pre-contrast EOB ratio). Portal blood flow was evaluated by CT during arterial portography.
RESULTS: Post-contrast EOB ratios significantly decreased as the degree of differentiation declined in DNs (1.00 ± 0.14) and well, moderately and poorly differentiated HCCs (0.79 ± 0.19, 0.60 ± 0.27, 0.49 ± 0.10 respectively). Gd-EOB-DTPA uptake, assessed by EOB enhancement ratios, deceased slightly in DNs and still more in HCCs, while there was no statistical difference in the decrease between different histological grades of HCC. Reductions in portal blood flow were observed less frequently than decreases in Gd-EOB-DTPA uptake in DNs and well-differentiated HCCs.
CONCLUSIONS: Reduced Gd-EOB-DTPA uptake might be an early event of hepatocarcinogenesis, preceding portal blood flow reduction. The hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI may help estimate histological grading, although difficulties exist in differentiating HCCs from DNs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20490505     DOI: 10.1007/s00330-010-1812-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  28 in total

1.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Authors:  J Bruix; M Sherman; J M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; J Rodés
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

2.  Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium.

Authors:  M Hayashi; O Matsui; K Ueda; Y Kawamori; M Kadoya; J Yoshikawa; T Gabata; T Takashima; A Nonomura; Y Nakanuma
Journal:  AJR Am J Roentgenol       Date:  1999-04       Impact factor: 3.959

3.  Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase.

Authors:  Kazuhiro Saito; Fumio Kotake; Naoki Ito; Taizo Ozuki; Ryuji Mikami; Kimihiko Abe; Yoko Shimazaki
Journal:  Magn Reson Med Sci       Date:  2005       Impact factor: 2.471

4.  Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.

Authors:  Bernd B Frericks; Christoph Loddenkemper; Alexander Huppertz; Steffi Valdeig; Andrea Stroux; Marion Seja; Karl-Jürgen Wolf; Thomas Albrecht
Journal:  AJR Am J Roentgenol       Date:  2009-10       Impact factor: 3.959

5.  Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.

Authors:  B Hamm; T Staks; A Mühler; M Bollow; M Taupitz; T Frenzel; K J Wolf; H J Weinmann; L Lange
Journal:  Radiology       Date:  1995-06       Impact factor: 11.105

6.  Early hepatocellular carcinoma: appearance at CT during arterial portography and CT arteriography with pathologic correlation.

Authors:  K Takayasu; Y Muramatsu; H Furukawa; F Wakao; N Moriyama; T Takayama; S Yamasaki; M Sakamoto; S Hirohashi
Journal:  Radiology       Date:  1995-01       Impact factor: 11.105

7.  Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.

Authors:  Seong Hyun Kim; Seung Hoon Kim; Jongmee Lee; Min Ju Kim; Yong Hwan Jeon; Yulri Park; Dongil Choi; Won Jae Lee; Hyo K Lim
Journal:  AJR Am J Roentgenol       Date:  2009-06       Impact factor: 3.959

8.  A comparison of hepatopathologists' and community pathologists' review of liver biopsy specimens from patients with hepatitis C.

Authors:  Maire Robert; Andre N Sofair; Ann Thomas; Beth Bell; Stephanie Bialek; Christopher Corless; Grace Van Ness; Sharon Huie-White; Nicole Stabach; Atif Zaman
Journal:  Clin Gastroenterol Hepatol       Date:  2008-12-13       Impact factor: 11.382

9.  Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time?

Authors:  Utaroh Motosugi; Tomoaki Ichikawa; Licht Tominaga; Hironobu Sou; Katsuhiro Sano; Shintaro Ichikawa; Tsutomu Araki
Journal:  Eur Radiol       Date:  2009-05-27       Impact factor: 5.315

10.  Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients.

Authors:  Paolo Sorrentino; Salvatore D'Angelo; Luciano Tarantino; Umberto Ferbo; Alessandra Bracigliano; Raffaela Vecchione
Journal:  World J Gastroenterol       Date:  2009-05-14       Impact factor: 5.742

View more
  71 in total

Review 1.  CT and MR cholangiography: advantages and pitfalls in perioperative evaluation of biliary tree.

Authors:  T Hyodo; S Kumano; F Kushihata; M Okada; M Hirata; T Tsuda; Y Takada; T Mochizuki; T Murakami
Journal:  Br J Radiol       Date:  2012-03-14       Impact factor: 3.039

2.  Prediction of the histopathological grade of hepatocellular carcinoma using qualitative diffusion-weighted, dynamic, and hepatobiliary phase MRI.

Authors:  Chansik An; Mi-Suk Park; Hyae-Min Jeon; Yeo-Eun Kim; Woo-Suk Chung; Yong Eun Chung; Myeong-Jin Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2012-03-22       Impact factor: 5.315

3.  Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study.

Authors:  Tatsuo Inoue; Tomoko Hyodo; Keiko Korenaga; Takamichi Murakami; Yasuharu Imai; Atsushi Higaki; Takeshi Suda; Toru Takano; Kennichi Miyoshi; Masahiko Koda; Hironori Tanaka; Hiroko Iijima; Hironori Ochi; Masashi Hirooka; Kazushi Numata; Masatoshi Kudo
Journal:  J Gastroenterol       Date:  2015-09-15       Impact factor: 7.527

4.  The essence of the Japan Radiological Society/Japanese College of Radiology Imaging Guideline.

Authors:  Yasuyuki Yamashita; Sadayuki Murayama; Masahiro Okada; Yoshiyuki Watanabe; Masako Kataoka; Yasushi Kaji; Keiko Imamura; Yasuo Takehara; Hiromitsu Hayashi; Kazuko Ohno; Kazuo Awai; Toshinori Hirai; Kazuyuki Kojima; Shuji Sakai; Naofumi Matsunaga; Takamichi Murakami; Kengo Yoshimitsu; Toshifumi Gabata; Kenji Matsuzaki; Eriko Tohno; Yasuhiro Kawahara; Takeo Nakayama; Shuichi Monzawa; Satoru Takahashi
Journal:  Jpn J Radiol       Date:  2016-01       Impact factor: 2.374

Review 5.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-09       Impact factor: 11.105

6.  Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI.

Authors:  H Rhee; M-J Kim; M-S Park; K A Kim
Journal:  Br J Radiol       Date:  2012-05-02       Impact factor: 3.039

7.  Incidence for progression of hypervascular HCC in hypovascular hepatic nodules showing hyperintensity on gadoxetic acid-enhanced hepatobiliary phase in patients with chronic liver diseases.

Authors:  Megumi Matsuda; Takaharu Tsuda; Shinji Yoshioka; Shigetoshi Murata; Hiroaki Tanaka; Masashi Hirooka; Yoichi Hiasa; Teruhito Mochizuki
Journal:  Jpn J Radiol       Date:  2014-05-24       Impact factor: 2.374

Review 8.  Appearance of hepatocellular carcinoma on gadoxetic acid-enhanced hepato-biliary phase MR imaging: a systematic review.

Authors:  Paola Erra; Marta Puglia; Alfonso Ragozzino; Simone Maurea; Raffaele Liuzzi; Giuseppe Sabino; Luigi Barbuto; Alberto Cuocolo; Massimo Imbriaco
Journal:  Radiol Med       Date:  2015-04-22       Impact factor: 3.469

9.  Texture analysis of MR images to identify the differentiated degree in hepatocellular carcinoma: a retrospective study.

Authors:  Mengmeng Feng; Mengchao Zhang; Yuanqing Liu; Nan Jiang; Qian Meng; Jia Wang; Ziyun Yao; Wenjuan Gan; Hui Dai
Journal:  BMC Cancer       Date:  2020-06-30       Impact factor: 4.430

10.  Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.

Authors:  Minghui Wu; Hongna Tan; Fei Gao; Jinjin Hai; Peigang Ning; Jian Chen; Shaocheng Zhu; Meiyun Wang; Shewei Dou; Dapeng Shi
Journal:  Eur Radiol       Date:  2018-11-07       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.